Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGOBSERVATIONAL

TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study

TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study - TIGER Meso Study

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The purpose of this post-authorisation medical device study is to obtain real life data on the use of Tumor Treating Fields (TTFields) in patients with pleural mesothelioma in routine clinical care. Patients with pleural mesothelioma and clinical indication for TTFields treatment will be enrolled in the study after signing Informed consent to use their data and process it centrally for research purposes. The clinical indication for TTFields is one of the inclusion criteria and is defined prior to inclusion by the treating physician.

Who May Be Eligible (Plain English)

Who May Qualify: - ≥ 18 years of age - diagnosed by tissue sample (biopsy-confirmed) pleural mesothelioma without any option of curative resection - Planned treatment with NovoTTF-200T System according to IFU and medical guidelines - Life expectancy more than 3 months at day of enrollment - Signed willing to sign a consent form for use and processing of data Who Should NOT Join This Trial: • Previous treatment with NovoTTF-200T for more than 1 week at day of enrollment Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * ≥ 18 years of age * Histologically confirmed pleural mesothelioma without any option of curative resection * Planned treatment with NovoTTF-200T System according to IFU and medical guidelines * Life expectancy more than 3 months at day of enrollment * Signed informed consent for use and processing of data Exclusion Criteria: • Previous treatment with NovoTTF-200T for more than 1 week at day of enrollment

Treatments Being Tested

DEVICE

TTFields

all patients will receive routine clinical care and TTFields

Locations (20)

Lungenklinik Gauting
Gauting, Bavaria, Germany
University Hospital Regensburg
Regensburg, Bavaria, Germany
Klinikum Bremen-Ost
Bremen, City state Bremen, Germany
Asklepios Klinikum Harburg
Harburg, Hamburg, Germany
University Medicine Göttingen
Göttingen, Lower Saxony, Germany
University Hospital Carl Gustav Carus Dresden
Dresden, Saxony, Germany
Charité Universitätsmedizin Berlin
Berlin, Germany
Lungenklinik Heckeshorn
Berlin, Germany
Kliniken der Stadt Koeln
Cologne, Germany
Florence-Nightingale-Hospital
Düsseldorf, Germany
Klinikum Essen-Mitte
Essen, Germany
University Hospital Essen
Essen, Germany
Niels-Stensen Hospital
Georgsmarienhütte, Germany
Krankenhaus Martha-Maria Halle-Doelau
Halle, Germany
Medizinische Hochschule Hannover
Hanover, Germany
Lungenklinik Hemer
Hemer, Germany
Evangelisches Krankenhaus Herne
Herne, Germany
Krankenhaus Bethanien Moers
Moers, Germany
GEHO Muenster
Münster, Germany
Fachkliniken Wangen
Wangen, Germany